Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001213900-25-103810·ENDRA Life Sciences Inc.
Schedule 13G ownership disclosure
ENDRA LIFE SCIENCES INC
Common Stock, par value $0.0001 · CUSIP: 29273B302
Event date: 2025-10-23
- Filing-level shares
- 115,477.00
- Percent of class
- 9.99%
- John Carter Lipman
Shares: 115,477.00 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-103810
- Form type
- SCHEDULE 13G
- Filer
- ENDRA Life Sciences Inc.
- CIK
- CIK 1681682
- Filed
- Oct 30, 2025
- Reporting period
- Oct 23, 2025
- Description
- Schedule 13G beneficial ownership